EUROAPI's Strategic Sale of Haverhill Site to Particle Dynamics

EUROAPI Strategically Divests Haverhill Site

EUROAPI has undertaken a significant step in optimizing its industrial footprint by announcing the sale of its Haverhill manufacturing site to Particle Dynamics, a prominent name in particle processing and delivery technologies. This transaction reinforces EUROAPI's commitment to its FOCUS-27 transformation plan aimed at redefining its operational strategies.

Details of the Transaction

The agreement, referred to as the share purchase agreement (SPA), enables Particle Dynamics to acquire 100% of EUROAPI UK Ltd, which oversees the operations at the Haverhill site. The completion of this transaction is expected to bolster Particle Dynamics' ability to offer enhanced solutions in the nutraceutical, consumer health, and pharmaceutical sectors.

EUROAPI's Vision for Future Operations

David Seignolle, the CEO of EUROAPI, highlighted the divestment as a crucial initiative to streamline operations and focus on strategic networks that align with the company’s vision. This strategic move allows EUROAPI to enhance its efficiency while supporting its UK workforce throughout this transition.

Particle Dynamics Takes the Lead

Particle Dynamics sees the acquisition as a vital expansion of their global capabilities in particle engineering. Nicolas Fortin, the company's CEO, emphasized their commitment to upgrading the Haverhill site, including investing in new commercial-scale spray drying technology. This advancement aims to enhance their contract development and manufacturing organization (CDMO) offerings to pharmaceutical innovators.

Financial Terms and Expectations

The financial details of the transaction reveal that it will have a limited impact on EUROAPI's financial statements for the initial half of 2025, as the operations and commitments associated with the site will transfer to Particle Dynamics. Notably, the Haverhill site generated approximately 35 million euros in net sales in a preceding year, with a large portion of that attributed to one significant client. This sale marks a strategic pivot for EUROAPI as it aims to redefine its market presence and operational framework.

About EUROAPI

EUROAPI is committed to innovating active ingredient solutions worldwide, focusing on sustainable practices to meet the diverse needs of its customers and patients. The company stands out as a leading player in the active pharmaceutical ingredient sector, boasting a robust portfolio of around 200 products along with extensive capabilities in research and development.

Commitment to Quality and Access

At the core of EUROAPI’s operations is the drive to ensure health through accessible treatment options. With approximately 3,430 dedicated employees at six manufacturing sites spread across Europe, EUROAPI guarantees the provision of high-quality active pharmaceutical ingredients to clients in over 80 countries.

Key Contacts

Media Relations:
Laurence Bollack
Tel.: +33 (0)6 81 86 80 19
Email: mr@euroapi.com

Investor Relations:
Sophie Palliez-Capian
Tel.: +33 (0)6 87 89 33 51
Email: Sophie.palliez@euroapi.com

Frequently Asked Questions

What is the recent development regarding EUROAPI?

EUROAPI has sold its Haverhill site to Particle Dynamics as part of its operational restructuring.

What is the rationale behind EUROAPI's sale?

The sale is part of a strategic plan to optimize EUROAPI's operations and enhance focus on core capabilities.

How will this impact EUROAPI's financials?

It is anticipated that the sale will have a limited immediate impact on EUROAPI's financial statements for the first half of 2025.

What are the future plans for the Haverhill site?

Particle Dynamics plans to invest in new technologies at the Haverhill site to expand its service offerings to pharmaceutical companies.

What should we know about EUROAPI's market position?

EUROAPI is recognized as a leading player in active pharmaceutical ingredients with a diverse technology portfolio serving clients globally.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.